HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Li-Fen Ren Selected Research

Acute Coronary Syndrome

2/2011[The clinical research of serum soluble CD40L and high sensitivie C-reactive protein in patients with acute coronary syndrome].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Li-Fen Ren Research Topics

Disease

4Neoplasms (Cancer)
02/2009 - 09/2006
3Stomach Neoplasms (Stomach Cancer)
12/2008 - 09/2006
1Lead Poisoning (Poisoning, Lead)
01/2014
1Atherosclerotic Plaque (Atheroma)
02/2011
1Acute Coronary Syndrome
02/2011
1Hematologic Neoplasms (Hematological Malignancy)
02/2009
1Neoplasm Metastasis (Metastasis)
12/2008
1Leukemia
06/2005

Drug/Important Bio-Agent (IBA)

3ArsenicIBA
12/2008 - 09/2006
3Arsenic Trioxide (Trisenox)FDA Link
12/2008 - 09/2006
2Aligeron (AS 2)IBA
02/2009 - 09/2006
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
12/2007 - 09/2006
1Insulin-Like Growth Factor I (IGF-1)IBA
01/2014
1C-Reactive ProteinIBA
02/2011
1CD40 Ligand (CD40L)IBA
02/2011
1Vascular Endothelial Growth Factor CIBA
12/2008
1Vascular Endothelial Growth Factor Receptor-3 (Flt 4)IBA
12/2008
1Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA
12/2007
1Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
12/2007
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
12/2007
1SurvivinIBA
06/2005
1arsenic disulfide (realgar)IBA
06/2005

Therapy/Procedure

1Aftercare (After-Treatment)
09/2006